Results 291 to 300 of about 8,895,509 (405)

A comprehensive murine clinical model for development of countermeasures and studying Mayaro virus infection. [PDF]

PLoS Negl Trop Dis
Rosa RB, Castro EF, Santos DO, Dantas WM, Tanaka CA, Mendes RPG, Silva RCD, Pereira CAM, Servato JPS, Costa ARGF, Bronzoni RVM, Pena LJ.   +11 more
europepmc   +1 more source

Infection and Resistance. An exposition of the biological phenomena underlying the occurrence of infection and the recovery of the animal body from infectious disease

, 1915
Hans Zinsser
openalex   +2 more sources

The life and habits of wild animals [PDF]

, 2008
Elliot, Daniel Giraud, Whymper, Edward, Wolf, Joseph   +2 more
core  

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Enemas with sucralfate and n-acetylcysteine can reduce inflammation and oxidative stress in colonic mucosa without fecal stream. [PDF]

Acta Cir Bras
Zanesco MC, Yoshitani MM, Fagundes FL, Campos FG, Pereira PP, Pereira QC, Pereira JA, Santos RC, Martinez CAR.   +8 more
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Trypanosoma vivax elicits both Th1 and Th2 immunological responses in experimentally infected cattle. [PDF]

PLoS One
Cholota-Iza C, Torres-Arias M, Chávez-Larrea MA, Bedoya-Paez F, Cisneros-Ruiz M, Morales-Moreno G, Ron-Román J, Saegerman C, Reyna-Bello A.   +8 more
europepmc   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Latent infection of Caenorhabditis elegans by Orsay virus induces age-dependent immunity and cross-protection. [PDF]

Nat Commun
Castiglioni VG, Villena-Giménez A, Herek D, González-Sánchez A, Toft C, Gómez GG, Elena SF.   +6 more
europepmc   +1 more source